Vimarsana
Biggest News Aggregation in the World

Page 3 - Phase Iii News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase Iii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase Iii Today - Breaking & Trending Today

Innovent thyroid eye therapy hits phase III goal, spurs China NDA - Vimarsana News

Innovent thyroid eye therapy hits phase III goal, spurs China NDA

In a crowded thyroid eye disease (TED) space, Innovent Biologics Inc. reported positive late-stage findings for its TED therapy, IBI-311, spurring the Suzhou, China-based biopharma to file for regulatory approval in China.

Bridgebio seeks Japan approval of acoramidis for rare heart disease - Vimarsana News

Bridgebio seeks Japan approval of acoramidis for rare heart disease

Armed with strong phase III safety data in Japanese patients, Palo Alto, Calif.-based Bridgebio Pharma Inc. is planning to file for Japan approval of its investigational drug acoramidis for a rare heart disorder.

Ambitious eCourts Ph-3 project gets Rs 825 crore this fiscal, Rs 1500 crore for next FY - Vimarsana News

Ambitious eCourts Ph-3 project gets Rs 825 crore this fiscal, Rs 1500 crore for next FY

The eCourts Mission Mode Project has been described by the government as the prime mover for improving access to justice using technology. As part of phase-III, the system will be migrated to cloud technology and the cost estimated for providing 25 petabytes (according to existing requirement) of cloud storage is Rs 1,205.20 crore.

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program - Vimarsana News

IRLAB is Granted an End-of-Phase 2 Meeting with the FDA for the Phase III-Ready Mesdopetam Program

GOTHENBURG, SWEDEN / ACCESSWIRE / January 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, January 3, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...

Source: yahoo.com
Tiger Census: 40-day Phase Iii Tiger Census Launched In Mtr | Coimbatore News - Vimarsana News

Tiger Census: 40-day Phase Iii Tiger Census Launched In Mtr | Coimbatore News

Udhagamandalam: A 40-day tiger census of phase III for the year 2023-24 through auto-camera traps was launched in the core area of the Mudumalai Tiger.